ARTICLE
14 June 2024

Holland & Knight Health Dose: June 4, 2024

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
United States Food, Drugs, Healthcare, Life Sciences

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • Senate Finance Committee Members Drafting Bipartisan GME Bill
  • Legislation to Prohibit Biotechnology Contracting with Foreign Adversaries
  • Sen. Paul Files Resolution on Laboratory Developed Tests
  • Congress Members Request Expanded Digital Therapeutics Coverage
  • Bipartisan Group of Legislators on E&C Health Subcommittee Introduce 340B Legislation
  • At Rep. Pallone's Request, GAO Releases Prior Authorization Report
  • Senate HELP Committee Approves Six Measures
  • House Hearings on Healthcare Consolidation
  • New Preventive Health Caucus
  • Congressional Retirements and Resignations
  • FDA: AI Guidance to Address Data Quality, Transparency, Standard Definitions
  • NIH Releases Equitable and Affordable Access Proposal and RFI
  • OCR Guidance Reversal
  • CMS Oncology Model Expansion

Read the full Health Dose ยป

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More